Janet Woodcock
Tracked across 1 events · 6 articles · First seen Feb 18, 2026 · Last active Jun 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: As the former drug director of the United States — Food and Drug Administration, Janet Woodcock supports the policy change, stating it reflects modern scientific advances and the agency's existing trend towards single-trial approvals for certain diseases.
Feb 18, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Janet Woodcock live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard